Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

447 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical benefit of treatment after trastuzumab emtansine for HER2-positive metastatic breast cancer: a real-world multi-centre cohort study in Japan (WJOG12519B).
Yokoe T, Kurozumi S, Nozawa K, Ozaki Y, Maeda T, Yazaki S, Onishi M, Fujimoto A, Nakayama S, Tsuboguchi Y, Iwasa T, Sakai H, Ogata M, Terada M, Nishimura M, Onoe T, Masuda J, Kurikawa M, Isaka H, Hagio K, Shimomura A, Okumura Y, Futamura M, Shimokawa M, Takano T. Yokoe T, et al. Among authors: nozawa k. Breast Cancer. 2021 May;28(3):581-591. doi: 10.1007/s12282-020-01192-y. Epub 2021 Jan 2. Breast Cancer. 2021. PMID: 33389616 Free PMC article.
The significance of biopsy scar excision at the time of skin- or nipple-sparing mastectomy with immediate breast reconstruction.
Ozaki Y, Yoshimura A, Sawaki M, Hattori M, Kotani H, Adachi Y, Kataoka A, Sugino K, Horisawa N, Endo Y, Nozawa K, Sakamoto S, Takatsuka D, Okumura S, Maruyama Y, Iwata H. Ozaki Y, et al. Among authors: nozawa k. Jpn J Clin Oncol. 2021 Aug 1;51(8):1212-1218. doi: 10.1093/jjco/hyab065. Jpn J Clin Oncol. 2021. PMID: 33942068 Free PMC article.
Adjuvant Olaparib in BRCA-Mutated Breast Cancer.
Nozawa K, Yoshimura A, Iwata H. Nozawa K, et al. N Engl J Med. 2021 Oct 7;385(15):1439. doi: 10.1056/NEJMc2112373. N Engl J Med. 2021. PMID: 34614336 No abstract available.
The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR status.
Horisawa N, Adachi Y, Takatsuka D, Nozawa K, Endo Y, Ozaki Y, Sugino K, Kataoka A, Kotani H, Yoshimura A, Hattori M, Sawaki M, Iwata H. Horisawa N, et al. Among authors: nozawa k. Breast Cancer. 2022 Mar;29(2):234-241. doi: 10.1007/s12282-021-01303-3. Epub 2021 Oct 7. Breast Cancer. 2022. PMID: 34622383
Impact of omitting fluorouracil from FOLFIRI plus bevacizumab as second-line chemotherapy for patients with metastatic colorectal cancer.
Matsubara Y, Masuishi T, Ogata T, Nakazawa T, Kato K, Nozawa K, Narita Y, Honda K, Bando H, Taniguchi H, Kadowaki S, Ando M, Tajika M, Muro K. Matsubara Y, et al. Among authors: nozawa k. J Cancer Res Clin Oncol. 2023 Mar;149(3):1123-1129. doi: 10.1007/s00432-022-03979-2. Epub 2022 Mar 22. J Cancer Res Clin Oncol. 2023. PMID: 35314873 Clinical Trial.
Association between bevacizumab with cancer drug therapies and drug-induced interstitial lung disease in patients with solid tumor: A systematic review and meta-analysis of randomized clinical trials.
Nozawa K, Takatsuka D, Endo Y, Horisawa N, Ozaki Y, Kataoka A, Kotani H, Yoshimura A, Hattori M, Sawaki M, Iwata H. Nozawa K, et al. Crit Rev Oncol Hematol. 2022 Jun;174:103703. doi: 10.1016/j.critrevonc.2022.103703. Epub 2022 May 6. Crit Rev Oncol Hematol. 2022. PMID: 35533814 Review.
447 results